Ultima-KLOW Blend 80mg
- Brand: Peptide Hubs
- Product Code: Ultima-KLOW Blend 80mg
- Availability: In Stock
-
$210.00
ULTIMA-KLOW BLEND 80mg | BPC-157, TB-500, KPV, & GHK-Cu Peptide Complex
The ULTIMA-KLOW BLEND is a precision-engineered peptide formulation designed for advanced research into tissue regeneration, inflammatory modulation, and cellular protection. This sophisticated multi-component blend provides a comprehensive model for studying the biochemical pathways of wound healing and regenerative biology through the synergistic action of BPC-1s7, TB-500, KPV, and GHK-Cu.
Specifications
| Product Name | BPC-157 + TB-500 + KPV + GHK-Cu (Klow Blend) |
| Composition (per vial) | BPC-157 10mg, TB-500 10mg, KPV 10mg, GHK-Cu 50mg |
| Total Content | 80mg lyophilised peptide blend |
| Purity | ≥99% (HPLC-verified) |
| Form | Lyophilised powder |
| Appearance | White to off-white powder |
| Concentration | 80mg per vial | 나
| Storage (Long-term) | –80°C (optimal) |
| Storage (Intermediate) | –20°C |
| Storage (Short-term) | 2–8°C or 20–25°C |
| Shelf Life | Stable for years under recommended conditions; 7 days once reconstituted at 2–8°C |
| Container Type | Sealed, desiccated vial |
Description & How it Works
The ULTIMA-KLOW BLEND is a meticulously formulated peptide complex designed for the investigation of complex biological cascades. By combining BPC-157, TB-500, KPV, and GHK-Cu, this formulation allows for the simultaneous study of angiogenesis, matrix remodelling, and inflammatory suppression. Each constituent peptide targets specific molecular pathways, creating a multifaceted approach to tissue repair and cellular restoration.
BPC-157 & TB-500: Angiogenesis and Matrix Regulation
The integration of BPC-157 and TB-500 facilitates a potent model for studying neovascularisation. BPC-157 promotes endothelial cell proliferation via VEGFR2 and eNOS pathways, while TB-50나 regulates actin dynamics and cellular motility. Together, they support the recruitment of fibroblasts and the regulation of the extracellular matrix, facilitating orderly wound closure and tissue remodeling.
KPV & GHK-Cu: Anti-Inflammatory & Antioxidant Support
KPV serves as a vital tool for studying inflammatory de-escalation. By acting as a competitive antagonist to NF-κB, it reduces the expression of pro-inflammatory cytokines like TNF-α and IL-6. GHK-Cu complements this by providing essential copper cofactors for lysyl oxidase and superoxide dismutase, promoting antioxidant enzymatic activity and assisting in the structural stabilisation of newly synthesised collagen.
Synergistic Clinical utility:
This blend is designed to mirror the natural stages of healing. From the initial reduction of acute inflammation (mediated by KPV and BPC-157) to the active stages of fibroblast proliferation and matrix deposition (mediated by TB-500 and GHK-Cu), the Klow Blend offers a high-fidelity model for regenerative research. Its design allows for the study of transition from acute injury to organised, stable tissue restoration.
Product Features:
- Four-Component Synergistic Blend: Features BPC-157, TB-500, KPV, and GHK-Cu for multi-pathway research.
- High Purity Standards: HPLC-verified purity of ≥99% for maximum analytical precision.
- Research-Grade Quality: Suitable for biotech, academic, and pharmaceutical research environments.
- Optimised Stability: Supplied in a lyophilised powder format to preserve biochemical integrity.
- Comprehensive Model: Ideal for studying angiogenesis, anti-inflammatory response, and matrix remodelling.
Quality Assurance:
Every batch of ULTIMA-KLOW BLEND is produced under strict GMP-certified manufacturing protocols. Each vial is accompanied by a Certificate of Analysis (CoA) to confirm molecular identity, ensuring complete traceability and reproducibility for all laboratory applications.